Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study

Inclusion Criteria

• •Willing to sign the informed consent
• •Has a clinical diagnosis of stable, clinically typical seborrheic keratosis
• •Medically determined candidate for at least 4 off-face SK lesions
• •Must have at least four treatable SK lesions and be willing to have NPS treatment on any three of the four treatable SK lesions. Treatable SK lesions must: be at least 1 mm in height, and no greater than 3 mm in height and not have a dimension perpendicular to the longest dimension of greater than 7.5mm or longer in any dimension than 20mm
• •Willing to have three of the designated SK lesions treated in a single treatment session
• •Willing to return to the PI's office for five additional study visits at specified intervals over 106-days
• •Agrees to high resolution photos of both the treated SK lesions and the untreated SK lesion
• •No subject identity will be possible via the "lesion-only" photograph
• •No evidence of active infection in the designated tissue prior to treatment
• •Is not allergic to Lidocaine or Lidocaine-like products
• •Not pregnant or lactating